Capricorn’s NewMed merger plan runs up against strong shareholder opposition
Certain shareholders have voiced concerns over Capricorn’s proposed merger with Israel’s NewMed, seeing it as “profoundly unfavourable.” Premium content Checking for account. You need javascript to validate your login status. Premium Premium content Subscribe to continue Become a PREMIUM Subscriber Do not want to miss out on any information about Offshore Energy? Subscribe to our …
Capricorn’s NewMed merger plan runs up against strong shareholder opposition Read More »
